CNBX PharmaceuticalsCNBX
13F holders, Q1 2024 (March 31)2holders
$0.00avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding CNBX Pharmaceuticals Inc. (CNBX) in their 13F filings. The largest holders were Archer Investment Corp ($0) and RFP Financial Group LLC ($0).
- Company
- CNBX Pharmaceuticals Inc.
- CUSIP
- 13764M209
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Archer Investment Corp | 0.00% | No change | 9 | $0 |
| RFP Financial Group LLC | 0.00% | No change | 15 | $0 |
"% of holder's portfolio" is CNBX's weight in each manager's 13F, not the share of CNBX Pharmaceuticals Inc. the manager owns.